Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the Global Prescription Weight-Loss Pills Market 2025-2034," provides a ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound ... now to their health care provider to ask for a prescription for the branded version of the medication.

Over the past decade researchers have uncovered significant links between many of our most commonly used drugs - and patients taking them suffering depression.

Injectable drugs like Ozempic and Wegovy may be new to most of the world, but the science behind them are familiar to those in the health field.